On June 25, we were delighted to welcome our attendees in Paris for the EviRed final meeting.
The event brought together leading national and international retina specialists, diabetologists, artificial intelligence experts, and the academic and industrial partners.
The day featured rich scientific discussions around the first results from the EVIRED cohort, including its clinical characteristics, the incidence and progression of diabetic retinopathy complications, and several ongoing research projects that will further advance our understanding of diabetic eye disease.
A major highlight of the meeting was the presentation of the final performance results of the EVIRED artificial intelligence algorithms. Their validation on one of the largest prospective multicenter cohorts of patients with diabetes in Europe represents an important milestone.
Beyond presenting the results, the meeting provided an excellent opportunity to exchange ideas, discuss future research directions, and strengthen collaborations between clinicians, researchers, engineers, and industry partners.
A heartfelt thank you to all investigators, clinicians, researchers, engineers, patients, and our academic and industrial partners for their dedication and outstanding collaboration throughout this journey.
